Fexofenadine
Back to searchMolecule Structure
Scientific Name
Fexofenadine
Description of the Drug
Fexofenadine is a selective H1-antagonist for the symptomatic treatment of seasonal allergic rhinitis and chronic idiopathic urticaria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00950
http://www.drugbank.ca/drugs/DB00950
Brand Name(s)
Not Available
Company Owner(s)
Dr Reddys Laboratories Limited, Atlantide Pharmaceuticals Ag, Aurolife Pharma Llc, Rising Pharma Holdings Inc, Teva Pharmaceuticals Usa Inc, Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd, Aurobindo Pharma Ltd, Impax Pharmaceuticals, P And L Development Llc, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4900 | ||||
| PharmGKB | PA449621 | ||||
| Human Metabolome Database | HMDB0005030 | ||||
| DrugBank | DB00950 | ||||
| PubChem: Thomson Pharma | 14835656 | ||||
| PubChem | 74685737 | 3348 | |||
| Mcule | MCULE-4193800017 | ||||
| NMRShiftDB | 70114033 | ||||
| LINCS | LSM-1770 | ||||
| Nikkaji | J413.164I | ||||
| BindingDB | 22874 | ||||
| EPA CompTox Dashboard | DTXSID00861411 | ||||
| DrugCentral | 1170 | ||||
| Brenda | 229451 | 229452 | 233989 | 164346 | 164347 |
| ChemicalBook | CB5473513 | ||||
| Guide to Pharmacology | 4819 | ||||
| rxnorm | FEXOFENADINE | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | ||
| KEGG Ligand | C06999 | ||||
| ChEBI | 5050 |
